Objective: Endothelial dysfunction, specifically endothelium-derived contracting factors have been implicated in the development of arterial conduit vasospasm. The potent vasoconstrictor endothelin-1 (ET-1) has received much attention in this regard. The present study was designed to evaluate the role of ET-1 in the development of endothelial dysfunction in human internal mammary arteries (IMA). To this aim, we examined the effects of specific and non-specific ET-receptor antagonists on endothelial function (assessed using acetylcholine (ACh)-induced vasodilation) in segments of IMA obtained during coronary artery bypass graft (CABG) surgery. Methods: Vascular segments of IMA were obtained from 51 patients undergoing elective coronary artery bypass graft (CABG) surgery and in vitro endothelium-dependent and -independent responses to ACh and sodium nitroprusside (SNP) were assessed. Isometric dose response curves (DRC) to ACh and SNP were constructed in pre-contracted rings in the presence and absence of bosentan (ET receptor A / B antagonist, 3 mM), BQ-123 (ET antagonist, 1 mM) and BQ-788 (ET antagonist, 1 mM) using the isolated organ bath apparatus. Percent A B maximum relaxation (%E ) and sensitivity (pEC ) were compared between interventions. Results: ACh caused dose-dependent max 50 endothelium-mediated relaxation in IMA (%E 4364, pEC 6.7460.12). In the presence of bosentan, BQ-123 and BQ-788 max 50 ACh-induced relaxation was significantly augmented (%E bosentan 6063, BQ-123 5664, BQ-788 5365 vs. control 4364, P,0.05) max without affecting sensitivity. The effects of these antagonists were endothelium-specific since endothelium-independent responses to SNP remained unaltered. Furthermore, the beneficial effects were independently and maximally mediated by ET and ET receptors (%E A B m a x BQ-123 5664 vs. BQ-788 5365 vs. bosentan 6063, P.0.05). Conclusions: These data uncover, for the first time, beneficial effects of ET receptor blockade on endothelial-dependent vasorelaxation in human IMA.
increased tone, decreased vasomotion, altered reactivity, a Demographic characteristics changes in structure / geometry, enhanced platelet aggrega-Number of patients 51 (30 men, tion and eventual atherosclerosis / graft failure [2] .
women)
Elucidating the mechanism(s) of endothelial dysfunction in bypass conduits has implications in terms of vessel spasm, Hypertension, n (%) 22 (43) Accumulating evidence suggests that endothelium-de-Diabetes, n (%) 19 (37) rived vasoconstrictors (thromboxane, prostanoids and Obesity (BMI$27), n (%) 20 (39) endothelin) may represent important mediators of peri-Family history, n (%) 31 (61) Hypercholesterolemia, n (%) 29 (57) operative spasm in arterial conduits [3] [4] [5] . Commendable Total cholesterol (mM) 6.260.5 studies from Schaff's group [3] have suggested that these Drugs vasoconstrictors may be released secondary to hypoxemia.
ACE inhibitors, n (%) 22 (43) The growing interest in the role of endothelin-1 (ET-1) as pro-thrombotic actions of ET-1 [11], targeting these de-dextrose (11.1) and disodium calcium edetate (0.026), fects may uncover novel approaches to the management of maintained at 378C and bubbled with 95% O and 5% CO 2 2 acute peri-operative spasm. Additionally, such interven-as described previously [12] . A progressive resting tension tions may serve to impede long-term graft atherosclerosis. of 2.5 g was applied (determined by preliminary experi-We herein describe, for the first time, the endothelial ments to afford the optimum tension-length relationship). protective effects of ET receptor blockade in IMA from All experiments were performed in the presence of in-25 patients undergoing CABG surgery. domethacin (10 mol / l) to prevent the synthesis of vascular prostaglandins. Following equilibration for 90 min, isometric dose response curves (DRC) were recorded 2. Methods using the following protocol: (a) cumulative DRC to 28 25 phenylephrine (10 to 10 ), (b) cumulative DRC to 2. The presence of the endothelium was confirmed in each immediately transferred to the pharmacology laboratory ring by relaxation to ACh. Bosentan, BQ-123 and BQ-788 (within 30 min). The vessels were cleaned of adherent are potent endothelin receptor antagonists at the contissue and cut into rings (|5 mm in length) and suspended centrations used [13-15]. in isolated tissue baths (volume 25 ml) containing oxy-All drugs and chemicals were obtained from Sigma (St. represents the number of patients employed in the study. 6.7460.12). This effect was endothelium-specific since it %E values were compared using a paired two-tailed was abolished in vessels denuded of the endothelium (by max t-test. The DRC were compared using repeated measures rolling vessels over a metallic probe, data not shown). The analysis of variance followed by a Newman-Keul's test effects of endothelin receptor blockade (with bosentan, for post-hoc comparisons. A P less than 0.05 was consid-BQ-123 and BQ-788) on ACh-mediated relaxation are ered to be statistically significant.
depicted in Figs Fig. 2 ; BQ-788 5365 vs. artery disease risk factors in this study population was control, P,0.05, Fig. 3 ). Furthermore, ACh-induced relaxation was improved to a similar degree with the three ET antagonists (Fig. 4 ). The beneficial effects were endo- thelium-independent vasodilator (SNP, 10 to 10 M), was unchanged following ET receptor blockade (not shown).
Discussion

Key observations
The main observations that emanate from this study are (i) endothelin-receptor blockade improves endothelial-mediated vasodilation in human IMA and (ii) the beneficial effects of endothelin antagonism are independently and equally mediated via ET and ET receptors. To our A B knowledge, this is the first report describing endothelial protective effects of ET antagonists on ACh-mediated vasorelaxation in IMA. Since endothelial dysfunction may contribute towards the development of peri-operative vasospasm [3] [4] [5] and graft atherogenicity [1, 2] , these results may have both acute and chronic implications for CABG surgery.
IMA, endothelial dysfunction and vasospasm: role of ET-1
The IMA is unequivocally the conduit of choice for . However, the small diameter of this arterial conduit predisposes it to acute peri-operative vasospasm which is a critical determinant of postoperative myocardial infarction and death following CABG surgery. Elucidating the mechanism(s) of vasospasm has been an area of intense research and studies by Schaff [3, 4] and Lin [5] are widely quoted. Although the definitive mechanisms remain unclear, it appears that endothelial dysfunction, specifically the release of thromboxane A and ET-1 may play a significant 2 role [3, 4, 19] . In addition to directly causing vascular smooth muscle contraction (via interaction with thromboxane and ET receptors on smooth muscle) these agents can impair endothelial function and vascular reactivity through inhibition of NO production / release [2] . Studies have nism underlies the production of ET-1 in IMA is unknown.
Another possibility is that cardiopulmonary bypass (with interacting with endothelium-derived NO to induce vasodithe associated inflammatory and cytokine response) may lation (transient) [11] . In IMA, Pate et al. [22] have result in the generation of potent vasoconstrictors and demonstrated that ET-1 mediates its effects predominately predispose to arterial spasm. We are currently investigating through ET receptors with lesser contribution from ET A B this hypothesis. Whatever the exact mechanism, it is receptors. This would imply that ET receptor blockade apparent that counteracting the actions of these contracting with BQ-123 would improve endothelial function to a factors may serve to restore endothelial function and greater extent than BQ-788 which was not the case in the vascular reactivity in IMA.
present study. As correctly pointed out by Pate A brief discussion of the potential mechanism(s) of tan. This is the first report depicting an equal contribution endothelial protection by ET blockers deserves mention.
of ET and ET receptors towards endothelial dysfunction A B
As highlighted earlier, endothelial dysfunction can be in IMA. The observation that combined ET receptor A / B viewed as the net balance of endothelium-derived vasocon-blockade (with bosentan) did not result in an additive / striction and vasodilation; derangements in either segment synergistic effect may suggest that antagonism of ET or A (or both) may predispose to increased tone and eventual ET receptors (individually) exerts maximal endothelial B vasospasm [2] . Therefore, the beneficial effects noted in protection. In addition, results from the present study were the present study may be due to (i) antagonism of ET-1 obtained in the presence of indomethacin suggesting that action on vascular smooth muscle ET receptors, (ii) blockade of prostaglandin synthesis may be required to improvement in NO-mediated vasodilation (by release of elicit the protective effects noted. tonic inhibition of ET-1 on NO production / release) or (iii) a combination of the above mechanisms. Alternatively, it 4.4. Limitations may be hypothesized that decreased endothelium-dependent relaxation in IMA is secondary to diminished NO Given the patient demographics, the contribution of production and that ET receptor blockade improves endo-individual risk factors towards endothelial dysfunction and thelial function merely by restoring the balance of NO / ET-the observed effects of ET receptor blockade cannot be 1. Although this is an attractive proposition, evidence assessed. All major risk factors for atherosclerotic vascular suggests that the l-arginine NO system is well preserved in disease have been associated with impaired NO activity human IMA [18] [19] [20] [21] . Furthermore, depressed endo- [23] . Hence it is plausible that the beneficial effects of ET thelium-dependent relaxation in these vessels is not related antagonism may extend non-specifically to any process to increases in superoxide production, deficiencies in l-that dampens endothelial function through affecting NO arginine, tetrahydrobiopterin or reduced membrane fluidity production, release or availability. Unfortunately, the study [16] . These data provide indirect evidence for a primary population undergoing bypass surgery has a clustering of role of vasoconstrictors in the development of endothelial CAD risk factors. Hence to find patients with one isolated dysfunction in IMA. Studies documenting increased ET-1 risk factor undergoing bypass surgery without other risk levels in segments of human IMA [9] lend further credence factors, such as hypertension, smoking, obesity, hyperto this concept. lipidemia, family history etc., is extremely difficult. In The present data raise an important question regarding addition finding patients just on angiotensin converting the involvement of ET versus ET receptors in mediating enzyme inhibitors or beta-blockers without any other risk A B endothelial protection. Conventionally, it is believed that factors would require us to screen |500-700 patients. the actions of ET-1 are facilitated through ET and ET Furthermore, it is impossible to discontinue medication A B receptors, the former mediating the majority of the vas-usage of these patients prior to CABG surgery. Of the 22 oconstrictor effects (on smooth muscle) and the latter patients on ACEI, 16 were on b-blockers, five on endo- 
